The forecast for tuberculosis cases in Japan shows a consistent decline from 18,350 cases in 2024 to 14,110 cases in 2028, reflecting a steady decrease year-on-year. This trend suggests a notable reduction in TB prevalence, indicating successful public health efforts or improvements in treatment and prevention strategies. The year-on-year percentage decrease is around 6% to 7% annually. Over the five-year period, the compound annual growth rate (CAGR) shows an average annual decrease of approximately 6%.
Future trends to watch for include potential impacts of emerging healthcare policies, innovations in treatment methodologies, and changes in global health dynamics that may affect TB prevalence. Additionally, any shifts in socioeconomic factors or healthcare access in Japan will be critical to monitor.
